Imaging the expression of transfected genes in vivo.
暂无分享,去创建一个
R. Blasberg | B. Gansbacher | G. Stockhammer | J. Tjuvajev | R. Desai | H. Uehara | K. Watanabe | Revathi Desai | Kyoichi A. Watanabe | Gunther Stockhammer | Hisao Uehara | Bernd Gansbacher | Ronald G. Blasberg
[1] J. Park,et al. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. , 1994, Cancer research.
[2] F Daghighian,et al. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Z. Ram,et al. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. , 1994, Journal of neurosurgery.
[4] R. Blasberg,et al. Iododeoxyuridine uptake and retention as a measure of tumor growth. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] E. Gilboa,et al. Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. , 1992, Blood.
[6] D. King. Fluorinated pyrimidines: a new change for old drugs. , 1991, Transplantation proceedings.
[7] R. Martuza,et al. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line , 1990, Journal of neuroscience research.
[8] T. Chou,et al. Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells. , 1988, Antiviral research.
[9] D. Tyrrell,et al. Synthesis and antiviral activity of IVFRU, a potential probe for the non-invasive diagnosis of herpes simplex encephalitis. , 1988, Drug design and delivery.
[10] E. Borrelli,et al. Targeting of an inducible toxic phenotype in animal cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[11] F. Moolten. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. , 1986, Cancer research.
[12] L. Wiebe,et al. Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracil. , 1986, The British journal of radiology.
[13] R. Rubenstein,et al. Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug: Autoradiographic assessment in an animal model , 1984, Annals of neurology.
[14] D. Rottenberg,et al. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. , 1982, Science.
[15] K. K. Ogilvie,et al. A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2 , 1982, Antimicrobial Agents and Chemotherapy.
[16] T. Chou,et al. Incorporation of metabolites of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine into deoxyribonucleic acid of neoplastic and normal mammalian tissues. , 1982, Biochemical pharmacology.
[17] Peter Molnar,et al. Application of Quantitative Autoradiographic Measurements in Experimental Brain Tumor Models , 1981 .
[18] K. Watanabe,et al. Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. , 1979, Journal of medicinal chemistry.
[19] T. Buckley,et al. Herpes simplex virus encephalitis treated with idoxuridine. , 1967, British medical journal.
[20] W. Prusoff. Synthesis and biological activities of iododeoxyuridine, an analog of thymidine. , 1959, Biochimica et biophysica acta.